Cabaletta Bio Inc

NASDAQ:CABA   3:59:54 PM EDT
12.33
+0.08 (+0.65%)
Earnings Announcements

Cabaletta Bio Reports Q4 2020 Financial Results

Published: 03/16/2021 11:50 GMT
Cabaletta Bio Inc (CABA) - Cabaletta Bio - Expects Cash and Cash Equivalents & Investments As of Dec 31, 2020 Will Enable It to Fund Operating Plan Through at Least Q3 of 2022.
Cabaletta Bio Inc Qtrly Net Loss per Voting and Non-voting Share, Basic and Diluted $0.40.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.50

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.61

More details on our Analysts Page.